Leishmania mexicana

Mechanisms of Action: Physiological Effects
Purine Nucleobase Transport in Amastigotes of Leishmania mexicana: Involvement in Allopurinol Uptake
Mohammed I. Al-Salabi, Harry P. de Koning
Experimental Therapeutics
Production and Characterization of Stable Amphotericin-Resistant Amastigotes and Promastigotes of Leishmania mexicana
Hamdan I. Al-Mohammed, Michael L. Chance, Paul A. Bates
Experimental Therapeutics
Antileishmanial Activity of the Terpene Nerolidol
Denise C. Arruda, Fabio Luiz D'Alexandri, Alejandro M. Katzin, Silvia R. B. Uliana
Mechanisms of Action: Physiological Effects
Inhibitors of Leishmania mexicana CRK3 Cyclin-Dependent Kinase: Chemical Library Screen and Antileishmanial Activity
Karen M. Grant, Morag H. Dunion, Vanessa Yardley, Alexios-Leandros Skaltsounis, Doris Marko, Gerhard Eisenbrand, Simon L. Croft, Laurent Meijer, Jeremy C. Mottram
Mechanisms of Resistance
Resistance to Pentamidine in Leishmania mexicana Involves Exclusion of the Drug from the Mitochondrion
Mireille Basselin, Hubert Denise, Graham H. Coombs, Michael P. Barrett
Susceptibility
In Vitro Activities of Iboga Alkaloid Congeners Coronaridine and 18-Methoxycoronaridine against Leishmania amazonensis
Jan Carlo Delorenzi, Leonardo Freire-de-Lima, Cerli R. Gattass, Deise de Andrade Costa, Liwen He, Martin E. Kuehne, Elvira M. B. Saraiva
Experimental Therapeutics
Efficacies of KY62 against Leishmania amazonensis andLeishmania donovani in Experimental Murine Cutaneous Leishmaniasis and Visceral Leishmaniasis
Hail M. Al-Abdely, John R. Graybill, Rosie Bocanegra, Laura Najvar, Eleanor Montalbo, Steven L. Regen, Peter C. Melby

Main menu

User menu

Search

Leishmania mexicana

Pages